Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well-controlled Type 2 diabetes

Aims To investigate the effect of metformin plus roziglitazione (RSGMET) compared with metformin alone (MET) on glycaemic control in well‐controlled Type 2 diabetes. Methods Subjects (drug naïve or those on glucose‐lowering monotherapy) were randomized (n = 526), following a 4‐week placebo run‐in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetic medicine 2006-10, Vol.23 (10), p.1069-1078
Hauptverfasser:	Stewart, M. W., Cirkel, D. T., Furuseth, K., Donaldson, J., Biswas, N., Starkie, M. G., Phenekos, C., Hamann, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Avandamet Biological and medical sciences Blood Glucose - analysis Diabetes Mellitus, Type 2 - drug therapy Diabetes. Impaired glucose tolerance Double-Blind Method Drug Therapy, Combination Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Female glycaemic control HbA1c targets Humans Hypoglycemic Agents - administration & dosage Male Medical sciences metformin Metformin - administration & dosage Middle Aged Thiazolidinediones - administration & dosage Type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!